blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2365080

EP2365080 - MCP-1 binding nucleic acids [Right-click to bookmark this link]
Former [2011/37]Mcp-1 binding nucleic acids
[2015/46]
StatusNo opposition filed within time limit
Status updated on  17.02.2017
Database last updated on 25.09.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
NOXXON Pharma AG
Max-Dohrn-Strasse 8-10
10589 Berlin / DE
[2015/46]
Former [2011/37]For all designated states
Noxxon Pharma AG
Max-Dohrn-Strasse 8-10
10589 Berlin / DE
Inventor(s)01 / Purschke, Werner
Wriezener Strasse 30
13359 Berlin / DE
02 / Jarosch, Florian
Düsterhauptstrasse 42
13469 Berlin / DE
03 / Eulberg, Dirk
Neue Welt 14
10437 Berlin / DE
04 / Klussmann, Sven
Thrasoltstrasse 1
10585 Berlin / DE
05 / Buchner, Klaus
Assmannshauser Strasse 3
14197 Berlin / DE
06 / Maasch, Christian
Liebfrauenweg 23
13509 Berlin / DE
 [2016/15]
Former [2011/37]01 / Purschke, Werner
Wriezener Strasse 30
13359 Berlin / DE
02 / Jarosch, Florian
Düsterhauptstrasse 42
13469 Berlin / DE
03 / Eulberg, Dirk
Neue Welt 14
10437 Berlin / DE
04 / Klussmann, Sven
Paulsborner Strasse 83
10709 Berlin / DE
05 / Buchner, Klaus
Assmannshauser Strasse 3
14197 Berlin / DE
06 / Maasch, Christian
Ernststrasse 27
13509 Berlin / DE
Representative(s)Bohmann, Armin K.
Bohmann
Anwaltssozietät
Nymphenburger Straße 1
80335 München / DE
[2016/15]
Former [2011/37]Bohmann, Armin K.
bohmann Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Application number, filing date11001720.914.02.2007
[2011/37]
Priority number, dateEP2006000293514.02.2006         Original published format: EP 06002935
EP2006002420222.11.2006         Original published format: EP 06024202
[2011/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2365080
Date:14.09.2011
Language:EN
[2011/37]
Type: B1 Patent specification 
No.:EP2365080
Date:13.04.2016
Language:EN
[2016/15]
Search report(s)(Supplementary) European search report - dispatched on:EP16.08.2011
ClassificationIPC:C12N15/115, A61K31/7088
[2011/37]
CPC:
C12N15/115 (EP,KR,US); C12N15/1136 (US); A61P1/00 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P15/00 (EP); A61P15/08 (EP); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P37/08 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); C12N15/11 (KR);
C12Q1/6813 (US); G01N33/566 (US); C12N2310/16 (EP,KR,US);
C12N2310/351 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/37]
TitleGerman:MCP-1-bindende Nukleinsäuren[2011/37]
English:MCP-1 binding nucleic acids[2015/46]
French:Acides nucléiques à liaison MCP-1[2011/37]
Former [2011/37]Mcp-1 binding nucleic acids
Examination procedure02.03.2011Examination requested  [2011/37]
14.02.2012Amendment by applicant (claims and/or description)
11.07.2014Despatch of a communication from the examining division (Time limit: M04)
21.11.2014Reply to a communication from the examining division
12.01.2015Communication of intention to grant the patent
26.06.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
19.08.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.10.2015Communication of intention to grant the patent
22.02.2016Fee for grant paid
22.02.2016Fee for publishing/printing paid
22.02.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07722818.7  / EP1984501
Opposition(s)16.01.2017No opposition filed within time limit [2017/12]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
19.08.2015Request for further processing filed
19.08.2015Full payment received (date of receipt of payment)
Request granted
06.10.2015Decision despatched
Fees paidRenewal fee
02.03.2011Renewal fee patent year 03
02.03.2011Renewal fee patent year 04
02.03.2011Renewal fee patent year 05
09.02.2012Renewal fee patent year 06
08.02.2013Renewal fee patent year 07
31.01.2014Renewal fee patent year 08
02.02.2015Renewal fee patent year 09
02.02.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.02.2007
AT13.04.2016
BE13.04.2016
BG13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
TR13.04.2016
GR14.07.2016
IS13.08.2016
PT16.08.2016
[2020/33]
Former [2020/15]HU14.02.2007
AT13.04.2016
BE13.04.2016
BG13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
TR13.04.2016
GR14.07.2016
PT16.08.2016
Former [2019/46]HU14.02.2007
AT13.04.2016
BE13.04.2016
BG13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2019/39]HU14.02.2007
AT13.04.2016
BE13.04.2016
BG13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2019/31]HU14.02.2007
AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/47]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/37]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/10]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SK13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/09]AT13.04.2016
BE13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/07]AT13.04.2016
BE13.04.2016
DK13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2017/03]AT13.04.2016
BE13.04.2016
ES13.04.2016
FI13.04.2016
IT13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2016/52]AT13.04.2016
ES13.04.2016
FI13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
SE13.04.2016
GR14.07.2016
PT16.08.2016
Former [2016/51]AT13.04.2016
ES13.04.2016
FI13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
GR14.07.2016
PT16.08.2016
Former [2016/50]AT13.04.2016
ES13.04.2016
FI13.04.2016
LT13.04.2016
LV13.04.2016
NL13.04.2016
PL13.04.2016
Former [2016/49]FI13.04.2016
LT13.04.2016
NL13.04.2016
PL13.04.2016
Former [2016/46]LT13.04.2016
Documents cited:Search[A]WO0038714  (CHILDRENS MEDICAL CENTER [US], et al) [A] 1-23 * page 19, paragraph 4 - page 20, paragraph 2 *;
 [A]EP1386972  (NOXXON PHARMA AG [DE]) [A] 1-23 * claims 1-13 *;
 [A]WO2005108431  (UNIV KENTUCKY RES FOUND [US], et al) [A] 1-23 * claim 15 *;
 [A]  - RHODES ANDREW ET AL, "The generation and characterisation of antagonist RNA aptamers to MCP-1", FEBS LETTERS, (20011005), vol. 506, no. 2, ISSN 0014-5793, pages 85 - 90, XP004308705 [A] 1-23 * figure 1 *

DOI:   http://dx.doi.org/10.1016/S0014-5793(01)02895-2
 [A]  - EULBERG DIRK ET AL, "Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist", NUCLEIC ACIDS RESEARCH, (2005), vol. 33, no. 4, ISSN 0305-1048, XP002441887 [A] 1-23 * page 5, column L, paragraph 2 - page 7, column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1093/nar/gni044
 [T]  - ANDERS H -J ET AL, "Spiegelmer NOX-E36 for the treatment of chronic inflammatory diseases: A new chemical entity that inhibits CCL2/MCP-1 signalling", NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, & 48TH SPRING MEETING OF THE DEUTSCHE-GESELLSCHAFT-FUR EXPERIMENTELLE-UNG-KLINISCHE-PHARMAKOLOGIE-UND-; MAINZ, GERMANY; MARCH 13 -15, 2007, (200703), vol. 375, no. Suppl. 1, ISSN 0028-1298, page 53, XP009086368 [T] 1-28 * abstract *
by applicantUS6011020
 EP1306382
 WO2005074993
    - "Methods in Molecular Biology", M.J. DAMHA; K.K. OGILVIE, Protocols for oligonucleotides and analogs, HUMANA PRESS INC., (1993), vol. 20, pages 81 - 114
    - WINCOTT F. ET AL., "Synthesis, deprotection, analysis and purification of RNA and ribosomes", NUCLEIC ACIDS RES, (19950725), vol. 23, no. 14, pages 2677 - 2684
    - DROLET ET AL., "Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys", PHARM RES, (2000), vol. 17, no. 12, pages 1503 - 1510
    - AKAHOSHI T; WADA C; ENDO H; HIROTA K; HOSAKA S; TAKAGISHI K; KONDO H; KASHIWAZAKI S; MATSUSHIMA K, "Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin- and tumor necrosis factor", ARTHRITIS RHEUM., (1993), vol. 36, page 762
    - ALAM R; YORK J; MOYARS M; STAFFORD S; GRANT JA; LEE J; FORSYTHE P; SIM T; IDA N, "Increased MCP-1, RANTES, and MIP-la in bronchoalveolar lavage fluid of allergic asthmatic patients", AM. J. RESPIR. CRIT. CARE MED, (1996), vol. 153, page 1398
    - ALTSCHUL S F; GISH W; MILLER W; MYERS E W; LIPMAN D J, "Basic local alignment search tool", J MOL BIOL., (1990), vol. 215, no. 3, pages 403 - 410
    - ALTSCHUL S F; MADDEN T L; SCHAFFER A A; ZHANG J; ZHANG Z; MILLER W; LIPMAN D J, "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", NUCLEIC ACIDS RES., (19970901), vol. 25, no. 17, pages 3389 - 3402
    - AMANN B; TINZMANN R; ANGELKORT B, "ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1", DIABETES CARE, (2003), vol. 26, page 2421
    - ANDERS H J; VIELHAUER V; FRINK M; LINDE Y; COHEN C D; BLATTNER S M; KRETZLER M; STRUTZ F; MACK M; GRONE H J, "A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation", J. CLIN. INVEST., (2002), vol. 109, page 251
    - ANDERS H J; VIELHAUER V; SCHL6NDORFF D, "Chemokines and chemokine receptors are involved in the resolution or progression of renal disease", KIDNEY INT., (2003), vol. 63, page 401
    - AURUP H ET AL., "Oligonucleotide duplexes containing 2'-amino-2'-deoxycytidines: thermal stability and chemical reactivity", NUCLEIC ACIDS RES, (19940111), vol. 22, pages 20 - 24
    - AUSTIN H 3D; MUENZ L R; JOYCE K M; ANTONOVYCH T T; BALOW J E, "Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome", KIDNEY INT., (1984), vol. 25, page 689
    - BAGGIOLINI M; DEWALD B; MOSER B, "Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines", ADV. IMMUNOL., (1994), vol. 55, page 97
    - BAGGIOLINI M, "Chemokines and leukocyte traffic", NATURE, (1998), vol. 392, page 565
    - BANBA N; NAKAMURA T; MATSUMURA M; KURODA H; HATTORI Y; KASAI K, "Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy", KIDNEY INT., (2000), vol. 58, page 684
    - BANISOR I; LEIST TP; KALMAN B, "Involvement of p-chemokines in the development of inflammatory demyelination", J. NEUROINFLAMMATION, (2005), vol. 2, page 7
    - BAZAN JF; BACON KB; HARDIMAN G; WANG W; SOO K; ROSSI D; GREAVES DR; ZLOTNIK A; SCHALL TJ, "A new class of membrane-bound chemokine with a CX3C motif", NATURE, (1997), vol. 385, page 640
    - BERKHOUT T A, "Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B", J BIOL CHEM, (1997), vol. 272, pages 16404 - 16413
    - BOHLE A; WEHRMANN M; BOGENSCHUTZ O; BATZ C; MULLER C A; MULLER G A, "The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis", PATHOL. RES. PRACT., (1991), vol. 187, page 251
    - BORING L; GOSLING J; CHENSUE S W; KUNKEL S L; FARESE R V JR; BROXMEYER H E; CHARO I F, "Impaired monocyte migration and reduced type 1 (Thl) cytokine responses in C-C chemokine receptor 2 knockout mice", J. CLIN. INVEST., (1997), vol. 100, page 2552
    - BORING L; GOSLING J; CLEARY M; CHARO I F, "Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis", NATURE, (1998), vol. 394, page 894
    - BORING L; GOSLING J; MONTECLARO F S; LUSIS A J; TSOU C L; CHARO I F, "Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein lalpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9", J. BIOL. CHEM., (1996), vol. 271, page 7551
    - BOSSINK A W; PAEMEN L; JANSEN P M; HACK C E; THIJS L G; VAN DAMME J, "Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis", BLOOD, (1995), vol. 86, page 3841
    - BOWER G; BROWN D M; STEFFES M W; VERNIER R L; MAUER S M, "Studies of the glomerular mesangium and the juxtaglomerular apparatus in the genetically diabetic mouse", LAB. INVEST., (1980), vol. 43, page 333
    - CHARO I F; MYERS S J; HERMAN A; FRANCI C; CONNOLLY A J; COUGHLIN S R, "Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails", PROC. NATL ACAD SCI. USA, (1994), vol. 91, page 2752
    - CHOW F Y; NIKOLIC-PATERSON D J; MA F Y; OZOLS E; ROLLINS B J; TESCH G H, "Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice", DIABETOLOGICA, (2007), vol. 5Q, page 471
    - CHOW F Y; NIKOLIC-PATERSON D J; OZOLS E; ATKINS R C; ROLLIN B J; TESCH G H, "Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin- treated mice", KIDNEY INT., (2006), vol. 69, page 73
    - CHOW F; OZOLS E; NIKOLIC-PATERSON D J; ATKINS R C; TESCH G H, "Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury", KIDNEY INT., (2004), vol. 65, page 116
    - COCKWELL P; HOWIE A J; ADU D; SAVAGE C O, "In situ analysis of C-C chemokine mRNA in human glomerulonephritis", KIDNEY INT., (1998), vol. 54, page 827
    - COHEN C D; GRONE H J; GR6NE E F; NELSON P J; SCHLöNDORFF D; KRETZLER M, "Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue", KIDNEY INT., (2002), vol. 61, page 125
    - CUMMINS L L ET AL., NUCLEIC ACIDS RES, (1995), vol. 23, pages 2019 - 2024
    - DALLA VESTRA M; MUSSAP M; GALLINA P; BRUSEGHIN M; CERNIGOI A M; SALLER A; PLEBANI M; FIORETTO P, "Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes", J. AM. SOC. NEPHROL., (2005), vol. 16, no. 1, page 78
    - DAWSON J; MILTZ W; MIR A K; WIESSNER C, "Targeting monocyte chemoattractant protein-1 signalling in disease", EXPERT OPIN. THER. TARGETS, (2003), vol. 7, page 35
    - DE BLEECKER J L; DE PAEPE B; VANWALLEGHEM I E; SCHRODER J M, "Differential expression of chemokines in inflammatory myopathies", NEUROLOGY, (2002), vol. 58, page 1779
    - DROLET D W; NELSON J; TUCKER C E; ZACK P M; NIXON K; BOLIN R; JUDKINS M B; FARMER J A; WOLF J L; GILL S C, "Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys", PHARM. RES., (2000), vol. 17, page 1503
    - EATON B E ET AL., "Let's get specific: the relationship between specificity and affinity", CHEMISTRY & BIOLOGY, (199510), vol. 2, no. 10, pages 633 - 638
    - EATON B E; GOLD L; HICKE B J; JANJIC N; JUCKER F M; SEBOSTA D P; TARASOW T M; WILLIS M C; ZICHI D A, "Post-SELEX combinatorial optimization of aptamers", BIOORG MED CHEM, (199706), vol. 5, no. 6, pages 1087 - 1096
    - ECONOMOU E; TOUSOULIS D; KATINIOTI A; STEFANADIS C; TRIKAS A; PITSAVOS C; TENTOLOURIS C; TOUTOUZA MG; TOUTOUZAS P, "Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty", INT. J. CARDIOL., (2001), vol. 80, page 55
    - EGASHIRA K; ZHAO Q; KATAOKA C; OHTANI K; USUI M; CHARO IF; NISHIDA K; INOUE S; KATOH M; ICHIKI T, "Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys", CIRC. RES., (2002), vol. 90, page 1167
    - FUJINAKA H; YAMAMOTO T; TAKEYA M; FENG L; KAWASAKI K; YAOITA E; KONDO D; WILSON CB; UCHIYAMA M; KIHARA I, "Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats", J. AM. SOC. NEPHROL., (1997), vol. 8, page 1174
    - FURUICHI K; WADA T; IWATA Y; KITAGAWA K; KOBAYASHI K-I; HASHIMOTO H; ISHIWATA Y; TOMOSUGI N; MUKAIDA N; MATSUSHIMA K, "Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia- reperfusion injury", J. AM. SOC. NEPHROL., (2003), vol. 14, page 1066
    - FURUTA T; SAITO T; OOTAKA T; SOMA J; OBARA K; ABE K; YOSHINAGA K, "The role of macrophages in diabetic glomerulosclerosis", AM. J. KIDNEY DIS., (1993), vol. 21, page 480
    - GALASSO J M; LIU Y; SZAFLARSKI J; WARREN J S; SILVERSTEIN F S, "Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain", NEUROSCIENCE, (2000), vol. 101, page 737
    - GALKINA E; LEY K, "Leukocyte recruitment and vascular injury in diabetic nephropathy", J. AM. SOC. NEPHROL., (2006), vol. 17, pages 368 - 377
    - GAO J L; KUHNS D B; TIFFANY H L; MCDERMOTT D; LI X; FRANCKE U; MURPHY P M, "Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor", J. FXP. MED, (1993), vol. 177, page 1421
    - GARCIA-ZEPEDA E A; COMBADIERE C; ROTHENBERG M E; SARAFI M N; LAVIGNE F; HAMID Q; MURPHY P M; LUSTER A D, "Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3", J. IMMUNOL., (1996), vol. 157, page 5613
    - GERARD C; ROLLINS, B J, "Chemokines and disease", NAT. IMMUNOL., vol. 6, page 1182
    - GONG X; GONG W; KUHNS D B; BEN-BARUCH A; HOWARD O M; WANG J M, "Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors", J. BIOL. CHEM., (1997), vol. 272, page 11682
    - GONZALO J A; LLOYD C M; WEN D; ALBAR J P; WELLS T N C; PROUDFOOT A; MARTINEZ-A C; DORF M; BJERKE T; COYLE A J, "The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness", J. EXP. MED, (1998), vol. 188, page 157
    - GORDILLO GM; ONAT D; STOCKINGER M; ROY S; ATALAY M; BECK FM; SEN CK, "A key angiogenic role of moncyte chemoattractant protein-1 in hemangioendothelioma proliferation", AM. J. PHYSIOL. CELL PHYSIOL., (2004), vol. 287, page C866
    - GREEN LS ET AL., "Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor", CHEM BIOL, (199510), vol. 2, no. 10, pages 683 - 696
    - HANDEL TM; DOMAILLE PJ, "Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer", BIOCHEMISTRY, (1996), vol. 35, page 6569
    - HARIGAI M; HARA M; YOSHIMURA T; LEONARD EJ; INOUE K; KASHIWAZAKI S, "Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium", CLIN. IMMUNOL. IMMUNOPATHOL., (1993), vol. 69, page 83
    - HASEGAWA H; KOHNO M; SASAKI M; INOUE A; ITO MR; TERADA M; HIESHIMA K; MARUYAMA H; MIYAZAKI J; YOSHIE O, "Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice", ARTHRITIS RHEUM., (2003), vol. 48, page 2555
    - HEATH H; QIN S ET AL., "Chemokine receptor usage by human eosinophils. The importance ` of CCR3 demonstrated using an antagonistic monoclonal antibody", J CLIN INVEST, (1997), vol. 99, page 178
    - HOLDSWORTH SR; KITCHING AR; TIPPING PG, "Chemokines as therapeutic targets in renal disease", CURR. OPIN. NEPHROL. HYPERTENS, (2000), vol. 9, page 505
    - HOLGATE ST; BODEY KS; JANEZIC A; FREW AJ; KAPLAN AP; TERAN LM, "Release of RANTES, MIP-la, and MCP-1 into asthmatic airways following endobronchial allergen challenge", AM. J. RESPIR. CRIT. CARE MED, (1997), vol. 156, page 1377
    - HOSAKA S ET AL., "Expression of the chemokine superfamily in rheumatoid arthritis", CLIN & EXP IMMUNOL, (199409), vol. 97, no. 3, pages 451 - 457
    - HUANG DR; WANG J; KIVISAKK P; ROLLINS BJ; RANSOHOFF RM, "Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen- specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis", J. EXP. MED, (2001), vol. 193, page 713
    - HULKOWER K; BROSNAN CF; AQUINO DA; CAMMER W; KULSHRESTHA S; GUIDA MP; RAPOPORT DA; BERMAN JW, "Expression of CSF-1, c-fins, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis", J. IMMUNOL., (1993), vol. 150, page 2525
    - HUMBERT M; YING S; CORRIGAN C; MENZ G; BARKANS J; PFISTER R; MENG Q; VAN DAMME J; OPDENAKKER G; DURHAM SR, "Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage- colony-stimulating factor, and IL-3", AM J RESPIR CELL MOL BIOL, (1997), vol. 16, page 11
    - IHM CG; PARK JK; HONG SP; LEE TW; CHO BS; KIM MJ; CHA DR; HA H, "A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells", NEPHRON, (1998), vol. 79, page 33
    - IYONAGA K; TAKEYA M; SAITA N; SAKAMOTO O; YOSHIMURA T; ANDO M; TAKAHASHI K, "Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases", HUM. PATHOL., (1994), vol. 25, page 455
    - JOHRER K; ZELLE-RIESER C; PERATHONER A; MOSER P; HAGER M; RAMONER R; GANDER H; HOLTL L; BARTSCH G; GREIL R, "Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma", CLIN CANCER RES, (2005), vol. 11, page 2459
    - JOLICOEUR C; LEMAY A; AKOUM A, "Comparative effect of danazol and a GnRH agonist on monocyte chemotactic protein-1 expression by endometriotic cells", AM. J REPROD IMMUNOL., (2001), vol. 45, page 86
    - JOSE PJ; GRIFFITHS-JOHNSON DA; COLLINS PD; WALSH DT; MOQBEL R; TOTTY NF; TRUONG O; HSUAN JJ; WILLIAMS TJ, "Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation", J. EXP. MED, vol. 179, page 881
    - KABURAGI Y; SHIMADA Y; NAGAOKA T; HASEGAWA M; TAKEHARA K; SATO S, "Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-la, MIP-1?, and eotaxin) in patients with atopic dermatitis", ARCH. DERMATOL. RES., (2001), vol. 293, page 350
    - KAWASAKI AM ET AL., "Uniformly modified 2'-deoxy-2'-fluoro-phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets", J MED CHEM, (1993), vol. 36, no. 7, pages 831 - 841
    - KENNEDY KJ; STRIETER RM; KUNKEL SL; LUKACS NW; KARPUS WJ, "Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-la and monocyte chemotactic protein-1", J NEUROIMMUNOL., (1998), vol. 91, page 98
    - KIM JS; GAUTAM SC; CHOPP M; ZALOGA C; JONES ML; WARD PA; WELCH KM, "Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat", J. NEUROIMMUNOL., (1995), vol. 56, page 127
    - KITAMOTO S; EGASHIRA K, "Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases", EXPERT REV. CARDIOVASC. THER., (2003), vol. 1, page 393
    - KLEINHANS M; TUN-KYI A; GILLIET M; KADIN ME; DUMMER R; BURG G; NESTLE FO, "Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma", BLOOD, (2003), vol. 101, page 1487
    - KOCH AE; KUNKEL SL; HARLOW LA; JOHNSON B; EVANOFF HL; HAINES GK; BURDICK MD; POPE RM; STRIETER RM, "Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis", J CLIN. INVEST., (1992), vol. 90, page 772
    - KOUNO J; NAGAI H; NAGAHATA T; ONDA M; YAMAGUCHI H; ADACHI K; TAKAHASHI H; TERAMOTO A; EMI M, "Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth", JNEUROONCOL, (2004), vol. 70, page 301
    - KURIHARA T; WARR G; LOY J; BRAVO R, "Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor", J EXP. MED, (1997), vol. 186, page 1757
    - KUSSER W, J BIOTECHNOL, (2000), vol. 74, pages 27 - 38
    - KUZIEL WA; MORGAN SJ; DAWSON TC; GRIFFIN S; SMITHIES O; LEY K; MAEDA N, "Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2", PROC. NATL ACAD SCI. USA, (1997), vol. 94, page 12053
    - LESNIK EA ET AL., "Oligodeoxynucleotides containing 2'-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes", BIOCHEMISTRY, (1993), vol. 32, no. 30, pages 7832 - 7838
    - LLOYD CM; MINTO AW; DORF ME; PROUDFOOT A; WELLS TNC; SALANT DJ; GUTIERREZ-RAMOS JC, "RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis", J. EXP. MED., (1997), vol. 185, page 1371
    - LU BB; RUTLEDGE BJ; GU L; FIORILLO J; LUKACS NW; KUNKEL SL; NORTH R; GERARD C; ROLLINS BJ, "Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1 deficient mice", J EXP. MED, (1998), vol. 187, page 601
    - LUBKOWSKI J; BUJACZ G; BOQUE L; DOMAILLE PJ; HANDEL TM; WLODAWER A, "The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions", NAT STRUCT BIOL, (1997), vol. 4, page 64
    - MACK M; CIHAK J; SIMONIS C; LUCKOW B; PROUDFOOT AE; PLACHY J; BRUHL H; FRINK M; ANDERS HJ; VIELHAUER V, "Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice", J. IMMUNOL., (2001), vol. 166, page 4697
    - MARTINELLI R; SABROE I; LAROSA G; WILLIAMS TJ; PEASE JE, "The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b", J BIOL CHEM, vol. 276, page 42957
    - MATSUSHIMA K; MORISHITA K; YOSHIMURA T; LAVU S; KOBAYASHI Y; LEW W; APPELLA E; KUNG HF; LEONARD EJ; OPPENHEIM JJ, "Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor", J. EXP. MED, (1989), vol. 167, page 1883
    - MCGINNIS S; MADDEN TL, "BLAST: at the core of a powerful and diverse set of sequence analysis tools", NUCLEIC ACIDS RES., (2004), vol. 32, pages W20 - W25
    - MEYER TW, "Immunosuppression for diabetic glomerular disease?", KIDNEY INT., (2003), vol. 63, page 377
    - MILLER MD; KRANGEL MS, "Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines", CRIT. REV. IMMUNOL., (1992), vol. 12, page 17
    - MILLER LE ET AL., JPHYSIOL, (1993), vol. 469, page 213
    - MORA C; NAVARRO JF, "The role of inflammation as a pathogenic factor in the development of renal disease in diabetes", CURR. DIAB. REP., (2005), vol. 5, page 399
    - MORII T; FUJITA H; NARITA T; SHIMOTOMAI T; FUJISHIMA H; YOSHIOKA N; IMAI H; KAKEI M; ITO S, "Association of monocyte chemoattractant protein- with renal tubular damage in diabetic nephropathy", J. DIABETES COMPLICATIONS, (2003), vol. 17, page 11
    - MURPHY PM; BAGGIOLINI M; CHARO IF; HEBERT CA; HORUK R; MATSUSHIMA K; MILLER LH; OPPENHEIM JJ; POWER CA, "International union of pharmacology. XXII. Nomenclature for chemokine receptors", PHARMACOL. REV., (2000), vol. 52, page 145
    - NAKAMURA H; WEISS ST; ISRAEL E; LUSTER AD; DRAZEN JM; LILLY CM, "Eotaxin and impaired lung function in asthma", AM J RESPIR CRIT CARE MED, (1999), vol. 160, page 1952
    - NAKAZAWA T; HISATOMI T; NAKAZAWA C; NODA K; MARUYAMA K; SHE H; MATSUBARA A; MIYAHARA S; NAKAO S; YIN Y, "Monocyte chemoattractant protein 1 mediated retinal detachment-induced photoreceptor apoptosis", PROC NATL. ACAD SCI. USA, (2007), vol. 104, page 2425
    - NAVARRO JF; MORA C; MACA M; GARCA J, "Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus", AM. J KIDNEY DIS., (2003), vol. 42, page 53
    - MYERS SJ; WONG LM; CHARO IF, "Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells", J. BIOL. CHEM., (1995), vol. 270, page 5786
    - NEEDLEMAN; WUNSCH, "A general method applicable to the search for similarities in the amino acid sequence of two proteins", J MOL BIOL., (1970), vol. 48, no. 3, pages 443 - 453
    - NELKEN NA; COUGHLIN SR; GORDON D; WILCOX JN, "Monocyte chemoattractant protein-1 in human atheromatous plaques", J. CLIN. INVEST., (1991), vol. 88, page 1121
    - NEOTE K; DIGREGORIO D; MAK JY; HORUK R; SCHALL TJ, "Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor", CELL, (1993), vol. 72, page 415
    - NINICHUK V; GROSS O; REICHEL C; KHANDOGA A; PAWAR RD; CIUBAR R; SEGERER S; BELEMEZOVA E; RADOMSKA E; LUCKOW B, "Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease", J. AM. SOC. NEPHROL., (2005), vol. 16, page 977
    - OGATA H; TAKEYA M; YOSHIMURA T; TAKAGI K; TAKAHASHI K, "The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats", J. PATHOL., (1997), vol. 182, page 106
    - OKUNO T; ANDOH A; BAMBA S; ARAKI Y; FUJIYAMA Y; FUJIYAMA M; BAMBA T, "Interleukin-1 p and tumor necrosis factor-a induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts", SCAND. J. GASTROENTEROL., (2002), vol. 37, page 317
    - OPPENHEIM JJ; ZACHARIAE CO; MUKAIDA N; MATSUSHIMA K, "Properties of the novel proinflammatory supergene "intercrine" cytokine family", ANNU. REV. IMMUNOL., (1991), vol. 9, page 617
    - PAWAR RD; PATOLE PS; ZECHER D; SEGERER S; KRETZLER M; SCHLöNDORFF D; ANDERS HJ, "Toll- like receptor-7 modulates immune complex glomerulonephritis", J. AM. SOC. NEPHROL., (2006), vol. 17, page 141
    - PEARSON; LIPMAN, "Improved tools for biological sequence comparison", PROC. NAT'L. ACAD. SCI. USA, (1988), vol. 85, page 2444
    - PEREZ DE LEMA G; MAIER H; FRANZ TJ; ESCRIBESE M; CHILLA MS; SEGERER S; CAMARASA N; SCHMID H; BANAS B; KALAYDJIEV S, "Chemokine receptor CCR2 deficiency reduces renal disease and prolongs survival in MRL/Ipr lupus-prone mice", J. AM. SOC. NEPHROL., (2005), vol. 16, page 3592
    - PEREZ DE LEMA G; MAIER H; NIETO E; VIELHAUER V; LUCKOW B; MAMPASO F; SCHLöNDORFF D, "Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis", J. AM. SOC. NEPHROL., vol. 12, page 1369
    - PONATH PD; QIN S; RINGLER DJ; CLARK-LEWIS I; WANG J; KASSAM N; SMITH H; SHI X; GONZALO JA; NEWMAN W, "Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils", J. CLIN. INVEST., (1996), vol. 97, page 604
    - PONATH PD; QIN S; POST TW; WANG J; WU L; GERARD NP; NEWMAN W; GERARD C; MACKAY CR, "Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils", J. EXP. MED., (1996), vol. 183, page 2437
    - POWER CA; MEYER A; NEMETH K; BACON KB; HOOGEWERF AJ; PROUDFOOT AE; WELLS TN, "Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line", J. BIOL. CHEM., (1995), vol. 270, pages 19495 - 19500
    - QI Z; WHITT I; MEHTA A; JIN J; ZHAO M; HARRIS RC; FOGO AB; BREYER MD, "Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance", AM. J. PHYSIOL. RENAL PHYSIOL., (2004), vol. 286, page F590
    - QIN S; LAROSA G; CAMPBELL JJ; SMITH-HEATH H; KASSAM N; SHI X; ZENG L; BUTHCHER EC; MACKAY CR, "Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential", EUR. J IMMUNOL., (1996), vol. 26, page 640
    - RANSOHOFF RM ET AL., "Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis", FASEB J, (199304), vol. 7, pages 592 - 600
    - RAPORT CJ; GOSLING J; SCHWEICKART VL; GRAY PW; CHARO IF, "Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-lp, and MIP-la", J. BIOL. CHEM., (1996), vol. 271, page 17161
    - RITZ E; RYCHLIK I; LOCATELLI F; HALIMI S, "End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions", AM. J. KIDNEY DIS., (1999), vol. 34, pages 795 - 808
    - ROLLINS BJ; STIER P; ERNST T; WONG GG, "The human homolog of the JE gene encodes a monocyte secretory protein", MOL. CELL BIOL., (1989), vol. 9, page 4687
    - ROLLINS BJ, "Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease", MOL. MED TODAY, (1996), vol. 2, page 198
    - ROVIN BH; RUMANCIK M; TAN L; DICKERSON J, "Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis", LAB. INVEST., (1994), vol. 71, page 536
    - RUFFING N; SULLIVAN N ET AL., "CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells", CELL IMMUNOL, (1998), vol. 189, page 160
    - SALCEDO R; PONCE ML; YOUNG HA; WASSERMAN K; WARD JM; KEINMAN HK; OPPENHEIM JJ; MURPHY WJ, "Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression", BLOOD, (2000), vol. 96, page 34
    - SAMSON M; LABBE O; MOLLEREAU C; VASSART G; PARMENTIER M, "Molecular cloning and functional expression of a new human CC-chemokine receptor gene", BIOCHEMISTRY, (1996), vol. 35, page 3362
    - SCHALL TJ; BACON KB, "Chemokines, leukocyte trafficking, and inflammation", CURR. OPIN. IMMUNOL., (1994), vol. 6, page 865
    - SCHNEIDER A; PANZER U; ZAHNER G; WENZEL U; WOLF G; THAISS F; HELMCHEN U; STAHL RA, "Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta", KIDNEY INT., (1999), vol. 56, page 135
    - SCHWARTING A; PAUL K; TSCHIRNER S; MENKE J; HANSEN T; BRENNER W; KELLY VR; RELLE M; GALLE PR, "Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice", J. AM. SOC. NEPHROL., (2005), vol. 16, page 3264
    - SCHWARTZ CJ; VALENTE AJ; SPRAGUE EA, "A modem view of atherogenesis", AM. J. CARDIOL., (1993), vol. 71, page 9B
    - SEGERER S; NELSON PJ; SCHLONDORFF D, "Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies", J. AM. SOC. NEPHROL., (2000), vol. 11, page 152
    - SHIMIZU S; NAKASHIMA H; MASUTANI K; INOUE Y; MIYAKE K; AKAHOSHI M; TANAKA Y; EGASHIRA K; HIRAKATA H; OTSUKA T, "Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice", RHEUMATOLOGY (OXFORD), (2004), vol. 43, page 1121
    - SMITH; WATERMAN, "Comparison of biosequences", ADV. APPL. MATH, (1981), vol. 2, no. 4, pages 482 - 489
    - SPRINGER TA, "Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration", ANNU. REV.PHYSIOL., (1995), vol. 57, page 827
    - STEINMAN L, "Immune therapy for autoimmune diseases", SCIENCE, (2004), vol. 305, page 212
    - SVENSSON M; SUNDKVIST G; ARNQVIST HJ; BJORK E; BLOHME G; BOLINDER J; HENRICSSON M; NYSTROM L; TORFFVIT O; WAEMBAUM I, "Signs of nephropathy may occur early in young adults with diabetes despite modem diabetes management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)", DIABETES CARE, (2003), vol. 26, page 2903
    - TAKEBAYASHI K; MATSUMOTO S; ASO Y; INUKAI T, "Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients", J. DIABETES COMPLICATIONS, (2006), vol. 20, page 98
    - TAKEYA M; YOSHIMURA T; LEONARD EJ; TAKAHASHI K, "Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody", HUM. PATHOL., (1993), vol. 24, page 534
    - TANG WW; QI M; WARREN JS, "Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN", KIDNEY INT., (1996), vol. 50, page 665
    - TASHIRO K; KOYANAGI I; SAITOH A; SHIMIZU A; SHIKE T; ISHIGURO C; KOIZUMI M; FUNABIKI K; HORIKOSHI S; SHIRATO I, "Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy", J. CLIN. LAB. ANAL., (2002), vol. 16, page 11
    - TESCH GH; MAIFERT S; SCHWARTING A; ROLLINS BJ; KELLEY VR, "Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice", J. EXP. MED, (1999), vol. 190, page 1813
    - TUAILLON N; SHEN DE F; BERGER RB; LU B; ROLLINS BJ; CHAN CC, "MCP-1 expression in endotoxin-induced uveitis", INVEST. OPHTHALMOL. VIS. SCI., (2002), vol. 43, page 1493
    - TUTTLE KR, "Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease", J. AM. SOC. NEPHROL., (2005), vol. 16, page 1537
    - UGUCCIONI M; MACKAY CR ET AL., "High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines", J CLIN INVEST, (1997), vol. 100, page 1137
    - "Annual data report: Incidence and prevalence 2004", AM. J KIDNEY DIS., (2004), vol. 45, page 77
    - UTIMURA R; FUJIHARA CK; MATTAR AL; MALHEIROS DM; NORONHA IL; ZATZ R, "Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes", KIDNEY INT., (2003), vol. 63, page 209
    - VAN RIPER G; SICILIANO S; FISCHER PA; MEURER R; SPRINGER MS; ROSEN H, "Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1", J. EXP. MED, (1993), vol. 177, page 851
    - VENKATESAN N ET AL., "NOVEL PHOSPHORMAIDITE BUILDING BLOCKS IN SYNTHESIS AND APPLICATIONS TOWARD MODIFIED OLIGONUCLEOTIDES", CURR MED CHEM, (2003), vol. 10, pages 1973 - 1991
    - VESTERGAARD C; JUST H; BAUMGARTNER NIELSEN J; THESTRUP-PEDERSEN K; DELEURAN M, "Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis", ACTA DERM. VENEREOL., (2004), vol. 84, page 353
    - VIEDT C; ORTH SR, "Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?", NEPHROL. DIAL. TRANSPLANT., (2002), vol. 17, page 2043
    - WADA T; FURUICHI K; SEGADA-TAKAEDA C; AHIMIZU M; SAKAI N; TAKEDA SI; TAKASAWA K; KIDA H; KOBAYASHI KI; MUKAIDA N, "MIP-la and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis", KIDNEY INT., (1999), vol. 56, page 995
    - WADA T; YOKOYAMA H; MATSUSHIMA K; KOBAYASHI KI, "Chemokines in renal diseases", INT. IMMUNOPHARMACOL., (2001), vol. 1, page 637
    - WADA T; YOKOYAMA H; FURUICHI K; KOBAYASHI KI; HARADA K; NARUTO M; SU SB; AKIYAMA M; MUKAIDA N; MATSUSHIMA K, "Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1)", FASEB J., (1996), vol. 10, page 1418
    - WANG X; YUE TL; BARONE FC; FEUERSTEIN GZ, "Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex", STROKE, (1995), vol. 26, page 661
    - WENZEL U; SCHNEIDER A; VALENTE AJ; ABBOUD HE; THAISS F; HELMCHEN UM; STAHL RA, "Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis", KIDNEY INT., (1997), vol. 51, page 770
    - YAMAGISHI S; INAGAKI Y; OKAMOTO T; AMANO S; KOGA K; TAKEUCHI M; MAKITA Z, "Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells", J. BIOL. CHEM., (2002), vol. 277, page 20309
    - YING S; ROBINSON DS; MENG Q; ROTTMAN J; KENNEDY R; RINGLER DJ; MACKAY CR; DAUGHERTY BL; SPRINGER MS; DURHAM SR, "Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells", EUR J IMMUNOL, (1997), vol. 27, page 3507
    - YING S; MENG Q; ZEIBECOGLOU K; ROBINSON DS; MACFARLANE A; HUMBERT M; KAY AB, "Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics", J LMMUNOL, (1999), vol. 163, page 6321
    - YLA-HERTTUALA S; LIPTON BA; ROSENFELD ME; SARKIOJA T; YOSHIMURA T; LEONARD EJ; WITZTUM JL; STEINBERG D, "Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions", PROC. NATL ACAD SCI. USA, (1991), vol. 88, page 5252
    - YOSHIMURA T; ROBINSON EA; TANAKA S; APPELLA E; LEONARD EJ, "Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin- stimulated human blood mononuclear leukocytes", J IMMUNOL., (1989), vol. 142, page 1956
    - YOZAI K; SHIKATA K; SASAKI M; TONE A; OHGA S; USUI H; OKADA S; WADA J; NAGASE R; OGAWA D, "Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions", J. AM. SOC. NEPHROL., (2005), vol. 16, page 3326
    - ZIMMET P; ALBERTI KG; SHAW J, "Global and societal implications of the diabetes epidemic", NATURE, (2001), vol. 414, page 782
 WO2002EP11950
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.